All the Active Ingredient Drugs
Tetanus Toxoid 5 Lf, Diphtheria Toxoid 2 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Pertactin 3 mcg, Fimbriae Types 2+3 5 mcg. VIAL: 1, 5 x 0.5 ml. Admin I.M. into
deltoid musc. See lit.
Active booster immunizat. against
diphth., tetanus and pertussis in ages
4-64 yrs.
C/I: Known system. hypersens. to any
compon. vaccine aft. prev. admin.
Encephalopathy not attributable to
another identifiable cause within 7 days of admin. prev. dose of any vaccine cont.
pertussis antigens (whole cell or
acellular). Progress. neurolog. disords.,
uncontroll. epilepsy, progress.
encephalopath. until tmt. regimen
established. Febrile or acute illness.
Diphtheria Toxoid Not less than 2 IU, Tetanus Immuneglobulin 5 Lf, Pertussis Toxoid 2.5 mcg, Filamentous Haemagglutinin 5 mcg, Fimbriae Types 2+3 5 mcg, Pertactin 3 mcg, Poliomyelitis Virus Type 1 40 D-antigen units, Poliomyelitis Virus Type 2 8 D-antigen units, Poliomyelitis Virus Type 3 32 D-antigen units. PRE-FILLED SYRINGES (susp. for inject.):
1, 10, 20. Starting from age 3, a single
I.M. 0.5 ml dose, in deltoid muscle,
applies to all age groups.
Active booster immunisat. for prevent.
diphth., tetanus, pertussis and polio,
from 3 yrs and over.
C/I: Hypersens., anaphylact./allerg.
reacts. to similar vaccine,
encephalopath. of unknown origin
within 7 days of prev. immunisat. dose
of any vaccine cont. pertussis antigens
(whole cell or acellular). Progress.
neurolog. disords., uncontroll. epilepsy,
progress. encephalopath. until tmt.
regimen established. Febrile or acute
illness. See lit.